CLINICAL_TRIALS
trial_result
· 2022-10-07
Clinical Trial Update: Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise [Phase 2]
Summary
A Phase 2 clinical trial evaluating abatacept for hospitalized COVID-19 patients with respiratory compromise was terminated; results were posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: COVID-19, SARS-CoV-2 | Phase 2 | Status: TERMINATED | Results posted: 2022-10-07